Cargando…

Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation

OBJECTIVE: To generate a clinical and pathologic phenotype of patients carrying rare loss-of-function mutations in ABCA7, identified in a Belgian Alzheimer patient cohort and in an autosomal dominant family. METHODS: We performed a retrospective review of available data records, medical records, res...

Descripción completa

Detalles Bibliográficos
Autores principales: Van den Bossche, Tobi, Sleegers, Kristel, Cuyvers, Elise, Engelborghs, Sebastiaan, Sieben, Anne, De Roeck, Arne, Van Cauwenberghe, Caroline, Vermeulen, Steven, Van den Broeck, Marleen, Laureys, Annelies, Peeters, Karin, Mattheijssens, Maria, Vandenbulcke, Mathieu, Vandenberghe, Rik, Martin, Jean-Jacques, De Deyn, Peter P., Cras, Patrick, Van Broeckhoven, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917260/
https://www.ncbi.nlm.nih.gov/pubmed/27037232
http://dx.doi.org/10.1212/WNL.0000000000002628
Descripción
Sumario:OBJECTIVE: To generate a clinical and pathologic phenotype of patients carrying rare loss-of-function mutations in ABCA7, identified in a Belgian Alzheimer patient cohort and in an autosomal dominant family. METHODS: We performed a retrospective review of available data records, medical records, results of CSF analyses and neuroimaging studies, and neuropathology data. RESULTS: The mean onset age of the mutation carriers (n = 22) was 73.4 ± 8.4 years with a wide age range of 36 (54–90) years, which was independent of APOE genotype and cerebrovascular disease. The mean disease duration was 5.7 ± 3.0 years (range 2–12 years). A positive family history was recorded for 10 carriers (45.5%). All patient carriers except one presented with memory complaints. The 4 autopsied brains showed typical immunohistochemical changes of late-onset Alzheimer disease. CONCLUSIONS: All patients carrying a loss-of-function mutation in ABCA7 exhibited a classical Alzheimer disease phenotype, though with a striking wide onset age range, suggesting the influence of unknown modifying factors.